Huons Global Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Huons Global Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Huons Global Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Huons Global Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Huons Global Co Ltd (Huons) develops, manufactures, and markets pharmaceutical and healthcare products. The company's primary activities include controlling and managing its subsidiaries, which are involved in pharmaceuticals, biopharmaceutical research and development, aesthetics, medical devices, and health food. The major products and services offered by the company through its subsidiaries include prescription drugs, botulinum toxin, fillers, cosmetics, and health functional foods. The major brands associated with Huons Global include Elravie Premier, Revoline, and Liztox. The company caters its products and services to hospitals, clinics, and pharmacies. The company operates through a network of subsidiaries and partners to distribute its products domestically and internationally. Huons is headquartered in Seongnam-si, Gyeonggi-do, South Korea.
Headquarters
South Korea
Address
9th floor, Huons Global Building, Building A, 17 Changup-ro, Sujeong-gu, Seongnam, 13449
Website
www.huonsglobal.com
Telephone
82 2 8544700
No of Employees
541
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
084110 (KDQ)
Revenue (2025)
$596.4M
4.2%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
11.8%
(2025 vs 2024)
Market Cap*
$199.2M
Net Profit Margin (2025)
XYZ
7.3%
(2025 vs 2024)
* As of and is in US$
Huons Global Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Local Anesthetics | Contract Manufacturing | Huons |
| Female Menopause Probiotics | Humedix | |
| Continuous Blood Glucose Monitors | Huons BioPharma | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In January, the company's subsidiary Humedix announced the launch of three types of ‘Elravie Premier’ fillers in Thailand. |
| 2026 | Regulatory Approval | In January, the company's subsidiary Humedixa announced that it has obtained regulatory approval in Syria for three products: ‘Elravie Deep Line Plus 1ml’, ‘Elravie Ultra Volume Plus 2ml’ and ‘Elravie Light Plus 1ml’. |
| 2026 | Regulatory Approval | In January, the company's subsidiary Huons BioPharma, secures NMPA approval for type A Botulinum Toxin in China. |
Competitor Comparison
| Key Parameters | Huons Global Co Ltd | Yuhan Corp | GC Biopharma Corp | Daewoong Pharmaceutical Co Ltd | HanAll Biopharma Co Ltd |
|---|---|---|---|---|---|
| Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
| City | Seongnam | Seoul | Yongin-si | Hwaseong | Daejeon |
| State/Province | - | - | - | - | Seoul |
| No. of Employees | 541 | 1,594 | 2,355 | 1,749 | 408 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yoon Sung-tae | Director; Co-Chief Executive Officer | Executive Board | 2025 | 62 |
| Soo-Young Song | Co-Chief Executive Officer; Director | Executive Board | 2025 | 63 |
| In-Sang Yoon | Director; Managing Director | Executive Board | - | 37 |
| Kyung-Ah Kim | President | Senior Management | - | 62 |
| Sang-Yeol Kim | Head - IT | Senior Management | - | 64 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer